Pallavi Pandey, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chemoembolization, Therapeutic | 9 | 2020 | 128 | 1.240 |
Why?
|
| Liver Neoplasms | 11 | 2020 | 4356 | 0.730 |
Why?
|
| Pancreatic Neoplasms | 5 | 2020 | 5444 | 0.630 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 7 | 2020 | 2809 | 0.590 |
Why?
|
| Hemochromatosis | 1 | 2017 | 175 | 0.520 |
Why?
|
| Pancreatic Cyst | 1 | 2019 | 372 | 0.490 |
Why?
|
| Carcinoma, Hepatocellular | 7 | 2020 | 2329 | 0.480 |
Why?
|
| Incidental Findings | 1 | 2019 | 698 | 0.460 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2018 | 523 | 0.440 |
Why?
|
| Fatty Liver | 1 | 2017 | 810 | 0.370 |
Why?
|
| Liver Cirrhosis | 2 | 2019 | 1960 | 0.350 |
Why?
|
| Cholangiocarcinoma | 3 | 2023 | 562 | 0.350 |
Why?
|
| Bile Duct Neoplasms | 3 | 2023 | 614 | 0.350 |
Why?
|
| Spleen | 3 | 2020 | 2295 | 0.310 |
Why?
|
| Neuroendocrine Tumors | 3 | 2019 | 659 | 0.290 |
Why?
|
| Magnetic Resonance Imaging | 14 | 2022 | 36570 | 0.290 |
Why?
|
| Cholangitis, Sclerosing | 2 | 2020 | 179 | 0.290 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 1757 | 0.270 |
Why?
|
| Elasticity Imaging Techniques | 2 | 2019 | 398 | 0.220 |
Why?
|
| Pancreas | 2 | 2019 | 1698 | 0.200 |
Why?
|
| Liver | 4 | 2020 | 7571 | 0.180 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2020 | 20710 | 0.170 |
Why?
|
| Cystadenoma, Serous | 1 | 2020 | 99 | 0.170 |
Why?
|
| Retrospective Studies | 21 | 2023 | 81657 | 0.160 |
Why?
|
| Focal Nodular Hyperplasia | 1 | 2018 | 29 | 0.150 |
Why?
|
| Adenoma, Liver Cell | 1 | 2018 | 32 | 0.150 |
Why?
|
| Splenic Diseases | 1 | 2017 | 91 | 0.140 |
Why?
|
| Mucins | 1 | 2019 | 569 | 0.130 |
Why?
|
| Reproducibility of Results | 5 | 2019 | 20146 | 0.120 |
Why?
|
| Hepatectomy | 1 | 2017 | 589 | 0.110 |
Why?
|
| Tachycardia, Ventricular | 1 | 2022 | 1313 | 0.110 |
Why?
|
| Defibrillators, Implantable | 1 | 2022 | 1499 | 0.100 |
Why?
|
| Algorithms | 4 | 2020 | 14073 | 0.100 |
Why?
|
| Observer Variation | 1 | 2018 | 2614 | 0.100 |
Why?
|
| Aged | 13 | 2020 | 171344 | 0.090 |
Why?
|
| Aged, 80 and over | 7 | 2019 | 59548 | 0.090 |
Why?
|
| Middle Aged | 14 | 2020 | 223267 | 0.080 |
Why?
|
| Tumor Burden | 3 | 2020 | 1902 | 0.080 |
Why?
|
| Liver Transplantation | 2 | 2018 | 2416 | 0.080 |
Why?
|
| Adenoma | 1 | 2018 | 2155 | 0.070 |
Why?
|
| Humans | 24 | 2023 | 766812 | 0.070 |
Why?
|
| Bile Ducts | 2 | 2018 | 288 | 0.070 |
Why?
|
| ROC Curve | 3 | 2020 | 3621 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2019 | 12985 | 0.070 |
Why?
|
| Male | 15 | 2020 | 364154 | 0.070 |
Why?
|
| Female | 16 | 2023 | 396532 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2018 | 3360 | 0.060 |
Why?
|
| Prognosis | 6 | 2023 | 29959 | 0.060 |
Why?
|
| Adult | 11 | 2020 | 223305 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 39312 | 0.050 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2023 | 303 | 0.050 |
Why?
|
| Disease Progression | 1 | 2019 | 13642 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2020 | 24299 | 0.050 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2020 | 100 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 6965 | 0.040 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2019 | 220 | 0.040 |
Why?
|
| Ethiodized Oil | 1 | 2018 | 26 | 0.040 |
Why?
|
| Italy | 1 | 2020 | 856 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2018 | 41706 | 0.040 |
Why?
|
| Elasticity | 1 | 2019 | 654 | 0.040 |
Why?
|
| Gadolinium | 1 | 2022 | 964 | 0.040 |
Why?
|
| Contrast Media | 2 | 2022 | 5329 | 0.040 |
Why?
|
| Cicatrix | 1 | 2022 | 798 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2019 | 10101 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 13644 | 0.030 |
Why?
|
| Treatment Outcome | 5 | 2020 | 65286 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2022 | 1089 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2019 | 1639 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2022 | 15425 | 0.030 |
Why?
|
| Benchmarking | 1 | 2020 | 1056 | 0.030 |
Why?
|
| Necrosis | 1 | 2018 | 1614 | 0.030 |
Why?
|
| Organ Size | 1 | 2018 | 2262 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 14653 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2022 | 2257 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2022 | 3681 | 0.030 |
Why?
|
| Brachytherapy | 1 | 2019 | 1221 | 0.020 |
Why?
|
| Embolization, Therapeutic | 1 | 2019 | 1403 | 0.020 |
Why?
|
| Young Adult | 3 | 2019 | 59939 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6514 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2018 | 2858 | 0.020 |
Why?
|
| Survival Rate | 1 | 2020 | 12826 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 11218 | 0.020 |
Why?
|
| Animals | 1 | 2017 | 168939 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2018 | 4047 | 0.010 |
Why?
|
| Software | 1 | 2018 | 4464 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2018 | 8928 | 0.010 |
Why?
|
| Adolescent | 2 | 2019 | 88902 | 0.010 |
Why?
|
| United States | 1 | 2020 | 72945 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 74889 | 0.010 |
Why?
|